Phase III study of NEPA, a fixed-dose combination of netupitant (NETU) and palonosetron (PALO), versus PALO for prevention of chemotherapy-induced nausea and vomiting (CINV) following moderately emetogenic chemotherapy (MEC).

被引：0
|
作者：
Aapro, Matti S.
Rossi, Giorgia
Rizzi, Giada
Palmas, Marco
Grunberg, Steven
机构：
[1] Clin Genolier, Genolier, Switzerland
[2] Helsinn Healthcare SA, Lugano, Switzerland
[3] Fletcher Allen Hlth Care, Burlington, VT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA9514
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase II dose-response study of palonosetron (PALO) in Japanese patients receiving moderately emetogenic chemotherapy (MEC) - PALO Japanese cooperative study group
    Tabei, Toshio
    Inoue, Kenichi
    Segawa, Yoshihiko
    Sano, Muneaki
    Sekine, Ikuo
    Tokuda, Yutaka
    Isobe, Hiroshi
    Ogura, Takashi
    Tsuboi, Masahiro
    Atagi, Shinji
    ANNALS OF ONCOLOGY, 2006, 17 : 302 - 303
  • [42] Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study
    Chang, Jianhua
    Chen, Gongyan
    Wang, Dong
    Wang, Guihua
    Lu, Shun
    Feng, Jifeng
    Li, Wei
    Li, Ping
    Lanzarotti, Corinna
    Chessari, Salvatore
    Zhang, Li
    CANCER MEDICINE, 2020, 9 (14): : 5134 - 5142
  • [43] Fixed Combination Antiemetic A literature review on prevention of chemotherapy-induced nausea and vomiting using netupitant/palonosetron
    Clark-Snow, Rebecca A.
    Vidall, Cheryl
    Bojeson, Sussanne
    Jahn, Patrick
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2018, 22 (02) : E52 - E63
  • [44] Real-world multicenter study of the safety and efficacy of netupitant plus palonosetron fixed-dose combination to prevent chemotherapy-induced nausea and vomiting among Malaysian patients receiving moderately or highly emetogenic chemotherapy
    Yusof, Mastura Md
    Abdullah, Matin Mellor
    Yap, Beng Khiong
    Ng, Soo Chin
    Low, John Seng Hooi
    Lam, Kai Seng
    Badruddin, Radzi Bin Ahmad Ahmad
    Lai, Christina Nye Bing
    Lau, Kah Liew
    Chong, Kwang Jeat
    Nonis, Joel Gabriel
    Annuar, Muhammad Azrif Ahmad
    Rahman, Mohd Haris Fadzillah Bin Abdul
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (04) : 419 - 427
  • [45] Noninferiority study evaluating dexamethasone (DEX)-sparing regimens administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) caused by high-dose cisplatin.
    Celio, Luigi
    Bonizzoni, Erminio
    Bria, Emilio
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] ANALYSIS OF PALONOSETRON VS ONDANSETRON IN PREVENTING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN PEDIATRIC PATIENTS RECEIVING MODERATELY OR HIGHLY EMETOGENIC CHEMOTHERAPY (MEC/HEC)
    Kovacs, G.
    Wachtel, A. E.
    Basharova, E. V.
    Spinelli, T.
    Nicolas, P.
    Kabickova, E.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S108 - S108
  • [47] A JAPANESE PHASE III OPEN-LABEL STUDY TO ASSESS SAFETY AND EFFICACY OF PALONOSETRON (PALO) 0.75 MG IV FOR PREVENTING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN REPEATED CYCLES OF HIGHLY EMETOGENIC CHEMOTHERAPY. PALO JAPANESE COOPERATIVE STUDY GROUP
    Sakai, H.
    Aogi, K.
    Yoshizawa, H.
    Masuda, N.
    Katakami, N.
    Yanagita, Y.
    Inoue, K.
    Kuranami, M.
    Mizutani, M.
    Masuda, N.
    ANNALS OF ONCOLOGY, 2008, 19 : 274 - 274
  • [48] NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron
    Matti Aapro
    Meinolf Karthaus
    Lee Schwartzberg
    Igor Bondarenko
    Tomasz Sarosiek
    Cristina Oprean
    Servando Cardona-Huerta
    Vincent Hansen
    Giorgia Rossi
    Giada Rizzi
    Maria Elisa Borroni
    Hope Rugo
    Supportive Care in Cancer, 2017, 25 : 1127 - 1135
  • [49] NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron
    Aapro, Matti
    Karthaus, Meinolf
    Schwartzberg, Lee
    Bondarenko, Igor
    Sarosiek, Tomasz
    Oprean, Cristina
    Cardona-Huerta, Servando
    Hansen, Vincent
    Rossi, Giorgia
    Rizzi, Giada
    Borroni, Maria Elisa
    Rugo, Hope
    SUPPORTIVE CARE IN CANCER, 2017, 25 (04) : 1127 - 1135
  • [50] Palonosetron (PALO) for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose melphalan prior to stem cell transplant (SCT)
    Giralt, S.
    Mangan, K.
    Maziarz, R.
    Bubalo, J. S.
    Beveridge, R.
    Hurd, D. D.
    Mendoza, F.
    Rubenstein, E. B.
    DeGroot, T. J.
    Schuster, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345